Am. J. Respir. Crit. Care Med., Volume 158, Number 2, August 1998, 444-451

Increased Intestinal Permeability Is Associated with the Development of Multiple Organ Dysfunction Syndrome in Critically Ill ICU Patients

CHRISTOPHER J. DOIG, LLOYD R. SUTHERLAND, J. DEAN SANDHAM, GORDON H. FICK, MARJA VERHOEF, and JON B. MEDDINGS

Departments of Medicine, and Community Health Science, University of Calgary, Calgary, Alberta, Canada

We conducted a prospective, observational cohort study designed to compare intestinal permeability (IP) and development of multiple organ dysfunction syndrome (MODS) in a subset of critically ill patients in an intensive care unit (ICU). All patients with an expected ICU stay of 72 h or more were entered into the study, and IP was determined on a daily basis whenever possible from the urinary fractional excretion of orally administered lactulose and mannitol (LMR). Forty-seven consecutive patients were studied, and 28 developed MODS either at the time of admission or during their ICU course. These patients, as a group, had significantly worse IP at admission than did a non-MODS cohort (LnLMR: 2.10 ± 1.10 versus 3.26 ± 0.83). Those patients who developed MODS following admission also had a significantly greater admission IP than did the non-MODS group (2.51 ± 0.85). Differences in IP between cohorts could not be explained by differences in the incidence of systemic inflammatory response syndrome (SIRS)/sepsis or shock. With multivariate regression analysis, the only parameter present on admission that was predictive of subsequent MODS was IP. Differences in IP and the severity of organ dysfunction were also present (MODS severity mild: 3.01 ± 0.72; moderate: 1.97 ± 0.69; and severe: 1.12 ± 0.96). Patients who developed MODS had a persistently abnormal IP during their ICU stay, and a significantly delayed improvement in their IP compared with the non-MODS cohort. We conclude that the development of MODS is associated with an abnormal and severe derangement of IP that is detectable prior to the onset of the syndrome. This observation lends credence to the premise that gastrointestinal (GI) dysfunction may be causally associated with the development of MODS in the critically ill patient.

This article has been cited by other articles:

				A. Sandek, J. Bauditz, A. Swidsinski, S. Buhner, J. Weber-Eibel, S. von Haehling, W. Schroedl, T. Karhausen, W. Doehner, M. Rauchhaus, et al. Altered Intestinal Function in Patients With Chronic Heart Failure J. Am. Coll. Cardiol., October 16, 2007; 50(16): 1561 - 1569. [Abstract] [Full Text] [PDF]

				J. J. Laurila, T. Karttunen, V. Koivukangas, P. A. Laurila, H. Syrjala, J. Saarnio, Y. Soini, and T. I. Ala-Kokko Tight Junction Proteins in Gallbladder Epithelium: Different Expression in Acute Acalculous and Calculous Cholecystitis J. Histochem. Cytochem., June 1, 2007; 55(6): 567 - 573. [Abstract] [Full Text] [PDF]

				C. Alberda, L. Gramlich, J. Meddings, C. Field, L. McCargar, D. Kutsogiannis, R. Fedorak, and K. Madsen Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial Am. J. Clinical Nutrition, March 1, 2007; 85(3): 816 - 823. [Abstract] [Full Text] [PDF]

				A. J. Moeser, P. K. Nighot, K. J. Engelke, R. Ueno, and A. T. Blikslager Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G647 - G656. [Abstract] [Full Text] [PDF]

				A. van den Berg, W. P. F. Fetter, E. A. M. Westerbeek, I. M. van der Vegt, H. R. A. van der Molen, and R. M. van Elburg The Effect of Glutamine-Enriched Enteral Nutrition on Intestinal Permeability in Very-Low-Birth-Weight Infants: A Randomized Controlled Trial JPEN J Parenter Enteral Nutr, September 1, 2006; 30(5): 408 - 414. [Abstract] [Full Text] [PDF]

				P. Farand, M. Hamel, F. Lauzier, G. E. Plante, and O. Lesur Review article: Organ perfusion/permeability-related effects of norepinephrine and vasopressin in sepsis: [Expose de synthese : Les effets relies a la perfusion et a la permeabilite organique de la norepinephrine et de la vasopressine durant le "sepsis"]. Can J Anesth, September 1, 2006; 53(9): 934 - 946. [Abstract] [Full Text] [PDF]

				D. Church, S. Elsayed, O. Reid, B. Winston, and R. Lindsay Burn Wound Infections Clin. Microbiol. Rev., April 1, 2006; 19(2): 403 - 434. [Abstract] [Full Text] [PDF]

				H. Knotzer, W. Pajk, M. W. Dunser, S. Maier, A. J. Mayr, N. Ritsch, B. Friesenecker, and W. R. Hasibeder Regional microvascular function and vascular reactivity in patients with different degrees of multiple organ dysfunction syndrome. Anesth. Analg., April 1, 2006; 102(4): 1187 - 1193. [Abstract] [Full Text] [PDF]

				P. E. Marik Monitoring Therapeutic Interventions in Critically Ill Septic Patients Nutr Clin Pract, October 1, 2004; 19(5): 423 - 432. [Abstract] [Full Text] [PDF]

				Y. A. Debaveye and G. H. Van den Berghe Is There Still a Place for Dopamine in the Modern Intensive Care Unit? Anesth. Analg., February 1, 2004; 98(2): 461 - 468. [Abstract] [Full Text] [PDF]

				T. J. Martikainen, J. J. Tenhunen, A. Uusaro, and E. Ruokonen The Effects of Vasopressin on Systemic and Splanchnic Hemodynamics and Metabolism in Endotoxin Shock Anesth. Analg., December 1, 2003; 97(6): 1756 - 1763. [Abstract] [Full Text] [PDF]

				R. Yang, X. Han, T. Uchiyama, S. K. Watkins, A. Yaguchi, R. L. Delude, and M. P. Fink IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G621 - G629. [Abstract] [Full Text] [PDF]

				R. Yang, D. J. Gallo, J. J. Baust, S. K. Watkins, R. L. Delude, and M. P. Fink Effect of hemorrhagic shock on gut barrier function and expression of stress-related genes in normal and gnotobiotic mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1263 - R1274. [Abstract] [Full Text] [PDF]

				C. M. Coopersmith, P. E. Stromberg, W. M. Dunne, C. G. Davis, D. M. Amiot II, T. G. Buchman, I. E. Karl, and R. S. Hotchkiss Inhibition of Intestinal Epithelial Apoptosis and Survival in a Murine Model of Pneumonia-Induced Sepsis JAMA, April 3, 2002; 287(13): 1716 - 1721. [Abstract] [Full Text] [PDF]

				K. T. Alscher, P. T. Phang, T. E. McDonald, and K. R. Walley Enteral feeding decreases gut apoptosis, permeability, and lung inflammation during murine endotoxemia Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G569 - G576. [Abstract] [Full Text] [PDF]